ACTU
Actuate Therapeutics, Inc.
$1.33
-0.19 (-12.50%)
At close · Jul 8
Market Cap
$31.82M
Shares
23,925,852
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-03-10 | The Citizens Life Sciences Conference | Conference |
| 2025-05-31 | Actuate Therapeutics Investor Event at ASCO to Discuss Elraglusib Phase 2 Topline Data in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | Event |